Hematuria laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ochuko Ajari (talk | contribs) No edit summary |
||
Line 22: | Line 22: | ||
* Antineutrophil cytoplasmic antibodies (ANCA) | * Antineutrophil cytoplasmic antibodies (ANCA) | ||
* Antistreptolysin O antibodies (ASO) | * Antistreptolysin O antibodies (ASO) | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Line 31: | Line 32: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category:Primary care]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 20:04, 15 May 2013
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria laboratory findings On the Web |
American Roentgen Ray Society Images of Hematuria laboratory findings |
Risk calculators and risk factors for Hematuria laboratory findings |
Steven C. Campbell, M.D., Ph.D.
Laboratory Findings
Often, the diagnosis is made on the basis of the medical history and some blood tests—especially in young people in whom the risk of malignancy is negligible and the symptoms are generally self-limited.
- Urinalysis for all patients
- Complete blood count (CBC)
- Calcium
- Uric acid
- Prothrombin time / Partial thromboplastin time (PT / PTT)
- Blood urea nitrogen (BUN) / creatinine
A more complete evaluation would include the following:
- C3 levels
- Red blood cells casts
- Cyroglobulins
- Hepatitis C antibodies
- Anti-glomerular basement membranes (GBM)
- Antinuclear anitbodies (ANA)
- Antineutrophil cytoplasmic antibodies (ANCA)
- Antistreptolysin O antibodies (ASO)